Does Weight Loss Improve Cardiovascular Outcomes?
In a session presented at the 2024 Heart in Diabetes Conference, Neha Pagidipati, MD, MPH, discussed weight change and its effects on cardiovascular complications.
GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD
In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.
CGM, Wearable Device Data to Improve Mortality, Establish Lifestyle Changes
In a session presented at the 2024 Heart in Diabetes Conference, researchers discussed the abilities of continuous glucose monitoring (CGM) to capture lifestyle data and improve mortality rates.
